Similar articles

• Ezetimibe prevents cholesterol gallstone formation in mice.

  Zúñiga S, Molina H, Azocar L, Amigo L, Nervi F, Pimentel F, Jarufe N, Arrese M, Lammert F, Miquel JF. Zúñiga S, et al. Liver Int. 2008 Aug;28(7):935-47. doi: 10.1111/j.1478-3231.2008.01808.x. Liver Int. 2008. PMID: 18783541
• Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.

  Wang HH, Portincasa P, de Bari O, Liu KJ, Garruti G, Neuschwander-Tetri BA, Wang DQ. Wang HH, et al. Eur J Clin Invest. 2013 Apr;43(4):413-26. doi: 10.1111/eci.12058. Epub 2013 Feb 19. Eur J Clin Invest. 2013. PMID: 23419155 Free PMC article. Review.
• Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.

  Ahmed MH. Ahmed MH. World J Gastroenterol. 2010 Apr 7;16(13):1555-7. doi: 10.3748/wjg.v16.i13.1555. World J Gastroenterol. 2010. PMID: 20355232 Free PMC article.
• Targets for current pharmacologic therapy in cholesterol gallstone disease.

  Di Ciaula A, Wang DQ, Wang HH, Bonfrate L, Portincasa P. Di Ciaula A, et al. Gastroenterol Clin North Am. 2010 Jun;39(2):245-64, viii-ix. doi: 10.1016/j.gtc.2010.02.005. Gastroenterol Clin North Am. 2010. PMID: 20478485 Free PMC article. Review.
• Simvastatin with or without ezetimibe in familial hypercholesterolemia.

  Davis HR Jr, Murgolo NJ, Graziano MP. Davis HR Jr, et al. N Engl J Med. 2008 Jul 31;359(5):531; author reply 532-3. N Engl J Med. 2008. PMID: 18677799 No abstract available.